Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
8.91
+0.04 (0.45%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $955.38 million as of September 18, 2026. Its market cap has increased by 124.32% in one year.
Market Cap
955.38M
Enterprise Value
597.85M
1-Year Change
124.32%
Ranking
Category
Stock Price
$8.91
ChartMarket Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has increased from $754.10M to $955.38M, an increase of 26.69%. That is a compound annual growth rate of 2.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 955.40M | 117.43% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SL Science Holding | 1.00B |
| Arbutus Biopharma | 1.00B |
| SpyGlass Pharma | 985.21M |
| Cybin | 979.01M |
| Sana Biotechnology | 968.43M |
| Lexicon Pharmaceuticals | 932.18M |
| Faeth Therapeutics | 909.07M |
| Inventiva | 903.84M |